Understanding the Lawsuits: What is the Lawsuit for Fenofibrate?
•
5 min read
In 2009, brand-name drug manufacturers Abbott Laboratories and Fournier Industrie et Sante settled a major class-action antitrust lawsuit for $250 million over the cholesterol drug fenofibrate (TriCor). For those asking **what is the lawsuit for fenofibrate**, the answer is not about a single case, but a series of legal challenges primarily focused on corporate misconduct and anticompetitive practices, not side effects.
